Lucia Hiľovská Selected Research

multidrug resistance-associated protein 1

10/2014

Single pre-treatment with hypericin, a St. John's wort secondary metabolite, attenuates cisplatin- and mitoxantrone-induced cell death in A2780, A2780cis and HL-60 cells.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Lucia Hiľovská Research Topics

Disease

3	Neoplasms (Cancer) 10/2015 - 10/2014
2	Breast Neoplasms (Breast Cancer) 10/2015 - 10/2014
1	Adenocarcinoma 01/2016
1	Carcinoma (Carcinomatosis) 01/2016
1	Ovarian Neoplasms (Ovarian Cancer) 01/2016
1	Leukemia 10/2015
1	Inflammation (Inflammations) 01/2015
1	Fever (Fevers) 01/2015
1	Pain (Aches) 01/2015

Drug/Important Bio-Agent (IBA)

3	ATP-Binding Cassette Transporters (ABC Transporters)IBA 10/2015 - 10/2014
2	ProadifenIBA 01/2016 - 10/2015
2	Cisplatin (Platino)FDA LinkGeneric 01/2016 - 10/2014
2	Proteins (Proteins, Gene)FDA Link 10/2015 - 10/2014
2	Mitoxantrone (Novantrone)FDA LinkGeneric 10/2015 - 10/2014
1	Mixed Function Oxygenases (Monooxygenases)IBA 10/2015
1	Apoptosis Regulatory ProteinsIBA 10/2015
1	Non-Steroidal Anti-Inflammatory Agents (NSAIDs)IBA 01/2015
1	hypericinIBA 10/2014
1	multidrug resistance-associated protein 1IBA 10/2014

Therapy/Procedure

2	Drug Therapy (Chemotherapy) 10/2015 - 01/2015